Related references
Note: Only part of the references are listed.DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells
Hong Qiu et al.
CANCER SCIENCE (2009)
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
A novel transforming growth factor β receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma
Hidemi Kawajiri et al.
CLINICAL CANCER RESEARCH (2008)
Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma
Scot Ebbinghaus et al.
CLINICAL CANCER RESEARCH (2007)
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression
Aristidis Moustakas et al.
CANCER SCIENCE (2007)
Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle
Mai Yamauchi et al.
CANCER SCIENCE (2007)
TGFβ1, TGFβ2, and TGFβ3 protein expression in gastric carcinomas:: Correlation with prognostics factors and patient survival
Konstantinos Vagenas et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma
Shi-Long Lu et al.
GENES & DEVELOPMENT (2006)
Epidemiology of gastric cancer
Katherine D. Crew et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells
H Azuma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-β1 in rat proximal tubular cells and mouse fibroblasts
T Nakagawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome
H Okano et al.
CLINICAL CANCER RESEARCH (2004)
CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation
K Shibuya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
YA Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor β in human cancer cells -: transcriptional activation and messenger RNA stabilization
M Okamoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
I Schwarte-Waldhoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
B Jimenez et al.
NATURE MEDICINE (2000)